Canada: Pot Of Gold: The Commercialization Of Medical Marijuana

On April 1, 2014, the new Marihuana for Medical Purposes Regulations (MMPR) supplanted the 13-year-old Marihuana Medical Access Regulations (MMAR). The MMPR overhauls Health Canada's medical marijuana program by replacing a system of small-scale home growers with a commercial network of licensed producers. Although a recent Federal Court decision has temporarily exempted certain home growers from the repeal of the MMAR, licensed producers are now set to engage in the large-scale production, packaging, and distribution of medical marijuana to patients across Canada.

The nascent medical marijuana supply industry is expected to generate over C$1.3 billion in domestic annual sales by 2024. In addition, the MMPR contains import and export provisions that can potentially position Canada as one of the world's top exporters of an increasingly legalized commodity. Despite these promising projections, the medical marijuana industry raises a number of difficult legal questions for industry, investors, health-care professionals and established businesses alike as they attempt to navigate an unfamiliar and untested regulatory landscape.


The federal government took its first tentative step towards the regulation of medical marijuana 13 years ago with the enactment of the MMAR. The MMAR eventually established a program under which individuals authorized by Health Canada were permitted to grow their own medical marijuana, whether by themselves or through a designated person, or purchase directly from Health Canada.

That two-pronged program was riddled with problems. For one, the proliferation of small-scale grow-operations in residential areas created safety hazards and a high risk for diversion of the narcotic into the illegal market. Further, Health Canada's own supply and distribution branch became increasingly expensive to administer as the number of program participants swelled. Stakeholders also complained about both the low quality of available stock and the high barriers to access, ultimately launching several court challenges that invalidated sections of the MMAR and kept the program in flux.

The new regime arose as a result of these challenges. In particular, the MMPR brings the supply and distribution system for medical marijuana closer in line with similar systems for pharmaceutical products by replacing in-home and government-subsidized grow operations with regulated commercial enterprises, and permitting doctors and some nurse practitioners to issue "medical documents" that allow patients to purchase designated quantities of medical marijuana from licensed producers.

The MMPR came into force on July 7, 2013 and was due to replace the MMAR in full by April 1, 2014. However, a recent Federal Court decision, Allard et al. v. Her Majesty the Queen in Right of Canada, has allowed certain home growers to continue small-scale operations pending the outcome of their constitutional challenge to the new regime. That decision is now under appeal.


The announcement of the MMPR regime in 2013 triggered a flood of licence applications and capital-raising activity. The current crop of licensed producers, which stands at 12 and increases on an almost-weekly basis, ranges from niche operations to sophisticated enterprises with sprawling production facilities and aggressive marketing strategies. One licensed producer is poised to go public on the TSX Venture Exchange after successfully completing a private placement with an investment dealer; several more have received funding from private equity investors.

The creation of a for-profit medical marijuana industry is likely to resonate through a number of ancillary industries, including security, software, equipment and logistics providers. These service demands will arise from both the normal course of business and the MMPR itself, which imposes stringent operational requirements on licensed producers.


Familiarity with the MMPR's legal framework will benefit both investors and established businesses. In particular, businesses that are in a position to service the medical marijuana sector can ensure regulatory compliance or offer value-added service by familiarizing themselves with requirements under the MMPR. Similarly, it is important for potential investors to conduct appropriate due diligence into issues such as the likelihood of a licence grant (if the investment target is an unlicensed entity) and the prevailing legal landscape. Unexpected developments, such as the recent Federal Court decision allowing certain patients to continue growing marijuana privately for the time being, can undermine the commercial market and dramatically reduce the value of an investment.

The new medical marijuana regime also raises difficult questions for health-care professionals. By allowing doctors (and nurse practitioners in some provinces) to issue medical documents for marijuana directly to patients, the MMPR effectively turns health-care professionals into the new gatekeepers for the narcotic. Several physicians' associations have spoken out against this enhanced role, citing efficacy and liability concerns. But others seem to be embracing the regulatory transition; over the past week, several physicians have announced plans to open specialist medical marijuana clinics.

Licensed producers themselves also face a host of legal issues and impediments. To start, Health Canada's threshold approval requirements, such as the establishment of quality control systems and standard operating procedures, can seem insurmountable to individuals without prior experience in the pharmaceutical sector. Moreover, some regulatory challenges will persist even after approval – for instance, although the Narcotic Control Regulations prohibit the advertising of narcotics to the general public, Health Canada's position on this issue is unclear, at least with respect to enforcement. As the industry develops, it is expected that Health Canada's well-established policies and enforcement practices with respect to the advertising of pharmaceutical products will come to inform its position with respect to medical marijuana. As such, industry participants should seek legal advice before proceeding with marketing or advertising campaigns, since the sanctions for noncompliance are onerous and may include the revocation of a producer's licence.

The regulatory scheme under the MMPR also exposes licensed producers to legal issues not routinely faced by pharmaceutical companies. For instance, since licensed producers will typically deal directly with patients or consumers rather than with hospitals and pharmacies, they must comply with requirements relating to the collection, use and disclosure of patient/consumer personal health information and with Canada's new anti-spam legislation as it relates to interactions with such individuals.

Finally, as the industry develops, licensed producers and third parties will likely enter into partnerships to streamline the processes of production, testing, packaging and distribution. Given that both producers' licences and patient registrations (i.e. the submission of a medical document by a patient to a licensed producer) are non-transferable, it is crucial for industry participants to properly structure contractual relationships, including partnerships and joint ventures, to avoid running afoul of the MMPR.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Events from this Firm
27 Oct 2016, Seminar, Toronto, Canada

Please join members of the Blakes Commercial Real Estate group as they discuss five key provisions of a commercial real estate purchase agreement that are often the subject of much negotiation but are sometimes misunderstood.

1 Nov 2016, Seminar, Toronto, Canada

What is the emotional culture of your organization?

Every organization and workplace has an emotional culture that can have an impact on everything from employee performance to customer or client satisfaction.

3 Nov 2016, Seminar, Toronto, Canada

Join leading lawyers from the Blakes Pensions, Benefits & Executive Compensation group as they discuss recent updates and legal developments in pension and employee benefits law as well as strategies to identify and minimize common risks.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.